The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
High prevalence of actionable germline variants in unselected endometrial cancer (EC) patients.
 
Monica Levine
No Relationships to Disclose
 
Rachel Pearlman
No Relationships to Disclose
 
Heather Hampel
Stock and Other Ownership Interests - Genome Medical
Consulting or Advisory Role - 23andMe; Genome Medical; InVitae; Promega
 
Casey Cosgrove
No Relationships to Disclose
 
David E. Cohn
Consulting or Advisory Role - Oncology Analytics
Research Funding - AbbVie (Inst); Advaxis (Inst); Agenus (Inst); Ajinomoto (Inst); Array BioPharma (Inst); AstraZeneca (Inst); Bristol-Myers Squibb (Inst); Clovis Oncology (Inst); Eisai (Inst); EMD Serono (Inst); EMD Serono (Inst); Ergomed (Inst); Exelixis (Inst); Genentech (Inst); GlaxoSmithKline (Inst); Gynecologic Oncology Group (Inst); Henry Jackson Foundation (Inst); ImmunoGen (Inst); INC Research (Inst); inVentiv Health (Inst); Janssen Research & Development (Inst); Ludwig Institute for Cancer Research (Inst); Novartis (Inst); NRG Oncology (Inst); Pfizer (Inst); PharmaMar (Inst); PRA International (Inst); Regeneron (Inst); Sanofi (Inst); Stemcentrix (Inst); Tesaro (Inst); Tricon Pharmaceuticals (Inst)
Other Relationship - Elsevier; UpToDate
 
Alexis Chassen
No Relationships to Disclose
 
Adrian Suarez
No Relationships to Disclose
 
Steven E. Waggoner
Consulting or Advisory Role - Regeneron
 
Caroline Billingsley
No Relationships to Disclose
 
Kimberly Erin Resnick
Speakers' Bureau - AstraZeneca (I); Merck (I)
 
Steve Andrews
No Relationships to Disclose
 
Sareena Singh
Speakers' Bureau - AstraZeneca; Merck
 
Eric Jenison
No Relationships to Disclose
 
Aine Emma Clements
Consulting or Advisory Role - AstraZeneca; AstraZeneca; Tesaro/GSK
 
Robert Neff
No Relationships to Disclose
 
Paul J. Goodfellow
Research Funding - Promega (Inst)